Extended Research Article
Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer's disease: the MADE Phase II, three-arm RCT
Robert Howard
,
Olga Zubko
,
Richard Gray
,
Rosie Bradley
,
Emma Harper
,
Linda Kelly
et al.
-
Journal:
Efficacy and Mechanism Evaluation Volume: 7, Issue: 2
-
Published:
24 April 2020